思路迪医药股份有限公司(01244)于2026年3月4日披露了截至2026年2月28日的股份变动月报。报告显示，公司注册股本与已发行股本均保持不变，期内未有新增股份发行或购回行为。
公司报告期内的注册股本为500,000,000股，面值每股0.001港元，总额维持在500,000港元。已发行股份总数于期末维持在258,177,000股，未出现新增股份发行、购回或注销的情况。
公告还披露了公司既有的股份期权计划，在此期间未因行使期权而增发股份，亦无因购回或转让库存股份导致的变动。截至本月末，股本结构整体保持稳定，公司确认已遵守香港联交所《上市规则》及相关法律规定。
本次月报由董事龚兆龙签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.